Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Enact Holdings, Inc. (ACT)
NASDAQFinancialsInsurance - SpecialtySnapshot 2026-11-05
$47.77-0.97%
Close 2026-11-05 · 1-day change
NASDAQFinancialsInsurance - SpecialtySnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.06 → 5.03 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ACT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain $500M share buyback authorization | A supporting condition in Enact Holdings, Inc.'s published investment case. The stated target is Maintain $500M buyback program. | Intact | Buyback program is canceled or materially reduced | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ACT is a financial business with a steady-profitability profile, rather than a turnaround or a high-growth story. Its multi-year view is intact, and the latest signal has shifted to favorable, though confidence in the evidence overall is medium.
The valuation evidence describes ACT as cheap versus peers, with expectations slightly below the model’s reference point. The priced-in assessment is justified and fragility is low, so the evidence does not point to unusually stretched expectations.
Near term, profitability has been stable across the last three reported quarters, and new insurance written rose in the latest quarter. Management has consistently emphasized prudent growth and capital return; recent results show progress on both. Near-term risk is quiet, but recent peer misses and a deep miss in ACT’s history remain reasons to watch execution.
The multi-year thesis depends on ACT sustaining disciplined growth and stable profitability without reversing its recent guidance increase. A guidance cut would also weaken confidence in management’s outlook. In the near term, Federal Reserve rate cuts could weigh on financial companies, while continued earnings strength and higher guidance from sector peers could support sector momentum.
Over the next 1 to 3 years, ACT’s long-term thesis rests on steady execution, prudent growth, and continued capital returns; the current evidence supports an intact view, but guidance credibility and sector conditions matter. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Enact Holdings, Inc.'s published investment case. The stated target is >= $4.5 EPS. |
| Intact |
| EPS falls below $4.0 for FY26 |
Diluted EPS: $1.15 per share FY2026-Q3; GAAP. Published target: >= $4.5 EPS. Annual target cannot be compared with a quarterly or TTM observation. Nov 5, 20261.15 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
New insurance written grows to at least $13B in 2026-Q1 | Enact Holdings grows new insurance written 30% year over year. | Intact | New insurance written falls below $10B in any quarter after 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 4 supplied quarters. Management reported: ““Affordability and mortgage rate volatility continued to shape housing activity, and against this backdrop we continued to demonstrate the resiliency of our model, prudently growing new insurance written while maintaining our focus on expense and risk management.” ““We continued to execute against our strategic priorities, prudently manage risk and invest for the future, strengthening our ability to deliver sustainable value for our stakeholders, while helping more people responsibly achieve the dream of homeownership.”” Revenue was $317.308 million in 2026-Q2. Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.97 → $5.03 · observed estimates
$1.28B → $1.28B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.97 | $1,282,111,000 | 3 / 2 |
| 2026-07-25 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-26 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-27 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-28 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-29 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-30 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-07-31 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-01 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-02 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-03 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-04 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-05 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-06 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-07 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-08 | $4.92 | $1,282,111,000 | 3 / 3 |
| 2026-08-09 | $5.01 | $1,283,657,670 | 3 / 3 |
| 2026-08-10 | $5.01 | $1,283,657,670 | 3 / 3 |
| 2026-08-11 | $5.01 | $1,273,918,250 | 3 / 4 |
| 2026-08-12 | $5.01 | $1,270,538,500 | 3 / 4 |
| 2026-08-13 | $5.01 | $1,270,538,500 | 3 / 4 |
| 2026-08-14 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-15 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-16 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-17 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-18 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-19 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-20 | $5.03 | $1,283,657,667 | 3 / 2 |
| 2026-08-21 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-22 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-23 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-24 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-25 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-26 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-27 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-28 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-29 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-30 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-08-31 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-01 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-02 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-03 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-04 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-05 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-06 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-07 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-08 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-09 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-10 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-11 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-12 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-13 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-14 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-15 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-16 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-17 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-18 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-19 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-20 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-21 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-22 | $5.03 | $1,278,384,667 | 3 / 3 |
| 2026-09-23 | $5.06 | $1,285,788,500 | 3 / 3 |
| 2026-09-24 | $5.06 | $1,285,788,500 | 3 / 3 |
| 2026-09-25 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-09-26 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-09-27 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-09-28 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-09-29 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-09-30 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-01 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-02 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-03 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-04 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-05 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-06 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-07 | $5.06 | $1,285,788,500 | 4 / 3 |
| 2026-10-08 | $5.05 | $1,284,263,500 | 4 / 3 |
| 2026-10-09 | $5.05 | $1,284,263,500 | 4 / 3 |
| 2026-10-10 | $5.05 | $1,284,263,500 | 4 / 3 |
| 2026-10-11 | $5.05 | $1,284,263,500 | 4 / 3 |
| 2026-10-12 | $5.05 | $1,284,263,500 | 4 / 3 |
| 2026-10-13 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-14 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-15 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-16 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-17 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-18 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-19 | $5.04 | $1,284,263,500 | 4 / 3 |
| 2026-10-20 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-21 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-22 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-23 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-24 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-25 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-26 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-27 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-28 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-29 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-30 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-10-31 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-11-01 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-11-02 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-11-03 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-11-04 | $5.03 | $1,284,263,500 | 4 / 3 |
| 2026-11-05 | $5.03 | $1,284,263,500 | 4 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 4 Hold · 2 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 2 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.